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Abstract 
Objective 
To determine whether a lifestyle intervention promoting a Mediterranean-style diet and physical 
activity results in improved lifestyle behaviors and weight loss among participants residing in the 
“stroke belt” of the Southeastern United States, where the rates of cardiovascular disease are 
disproportionately high, particularly among people with diabetes and African Americans. 
Research Design and Methods 
The study was designed as a two-year prospective cohort study to evaluate the lifestyle 
intervention with an embedded randomized controlled trial (RCT) of a maintenance weight loss 
intervention during the second year.  There were three phases of the study.  Phase I (6 months 
long) was an individually-tailored lifestyle intervention promoting a Mediterranean-style dietary 
pattern and increased walking.  Phase II (also 6 months long) included an optional 16-week 
weight loss intervention for participants whose BMI was at least 25 kg/m
2
 or a maintenance of 
lifestyle intervention for all others.  Phase III (12 months long) included optional participation in 
a maintenance of weight loss RCT for participants who lost at least 8 lbs or the maintenance of 
lifestyle intervention for all others.  The Phase II weight loss intervention was offered in two 
formats: 16 weekly group sessions or 5 group sessions and 10 phone calls.  Changes in lifestyle 
behaviors, physiologic cardiovascular intermediate outcomes, and weight were assessed at 6, 12, 
and 24 month follow-up visits and analyzed to determine differences by diabetes status and then 
by race within those groups. 
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Results 
Baseline characteristics (n=339): mean age 56, 77% female, 65% black, 37% had diabetes; mean 
weight was 103kg for those with diabetes, 95kg for those without diabetes.  Outcomes: 
Participants with diabetes reported increased walking and activity times at 24 months, 
particularly among blacks.  Systolic and diastolic blood pressures were reduced by over 8 mmHg 
at 24 months among black participants with diabetes.  Participants with diabetes demonstrated 
greater weight loss than those without diabetes; those with diabetes lost an average of 1.2 kg, 1.5 
kg, and 3.7 kg at 6, 12, and 24 months, respectively.  The intervention was highly acceptable in 
this population. 
Conclusions 
Overall, participants with diabetes achieved a 3.7 kg sustained weight loss at 24 months.  The 
study interventions also led to improved blood pressure, physical activity, diet quality, and a 
trend toward improvement in hemoglobin A1c among participants with diabetes.  Further study 
of the lifestyle intervention is warranted with a RCT. 
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Introduction 
The Southeastern United States, particularly the “stroke belt,” has high rates of cardiovascular 
disease (CVD),
1-4
 attributed in part to the fact that residents are more likely to be of low 
socioeconomic status, obese, and sedentary.
5-7
  African Americans also have increased rates of 
cardiovascular disease
3,4,8
 and are more represented in the Southeastern United States.  The diet 
in the Southeast also tends to be less healthful compared to other areas of the United States,
9-11
 
which further contributes to the observed higher rates of obesity, diabetes, and CVD.
12,13
 
 
Several studies have been published looking at lifestyle interventions to promote weight loss and 
reduce CVD in populations with high rates of diabetes; however many of them did not achieve 
the desired outcome of CVD reduction.  Franz et al. published a systematic review and meta-
analysis of lifestyle weight-loss intervention outcomes in adults with type 2 diabetes mellitus.
14
  
They reported that only the Look AHEAD trial and another Mediterranean diet-based 
intervention achieved at least 5% weight loss as well as improvement in other intermediate 
cardiovascular outcomes (blood pressure, lipids, and hemoglobin A1c).  Both of these trials also 
included a physical activity component and frequent contact with healthcare providers.
14
  
However, Look AHEAD did not actually demonstrate a reduction in CVD events.
15
  The 
PREDIMED trial was the first study to document the ability of a lifestyle intervention to 
substantially reduce cardiovascular events among participants with and without diabetes; they 
did so using a Mediterranean diet.
16
 One theory for why prior studies such as Look AHEAD
17
 
and the Diabetes Prevention Program
18
 failed to reduce CVD events was because they 
recommended a low-fat diet as part of their intervention whereas high quality fats are an 
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important factor in reducing CVD.
12
  Therefore, a Mediterranean-type diet with high quality fats 
is a critical component to a lifestyle intervention that successfully reduces CVD. 
 
For these reasons, our group developed a culturally-appropriate lifestyle intervention specifically 
for a high-risk, racially diverse population like much of the Southeastern United States with a 
focus on improving diet quality using a Mediterranean-like diet, increasing physical activity, and 
promoting weight loss.  The main results of the Heart Healthy Lenoir Project (HHLP) lifestyle 
study have previously been published.
19
  This paper specifically focuses on how diabetes status 
and race influence lifestyle and weight loss outcomes as this type of intervention has not 
previously been studied to determine its effectiveness and acceptability in a largely African 
American, high-risk population. 
 
Methods 
Study Overview 
HHLP was a collaborative research effort designed to reduce CVD risk and disparities in risk in 
Lenoir County, North Carolina.  The project consisted of three coordinated studies focusing on 
lifestyle, high blood pressure, and genomics as they affect cardiovascular risk.
20
  The studies 
were conducted in Lenoir County because of its location in the “stroke belt” with rates of CVD 
higher than state and national averages as well as its population that is predominantly lower 
socioeconomic status and 40% African American.
21
 
 
HHLP lifestyle study participants were recruited from the Lenoir County community as well as 
from the HHLP high blood pressure study which enrolled participants from local clinical 
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practices.
22
  The HHLP lifestyle study was designed and conducted with input from a local 
community advisory committee
20
 and was approved and monitored by the University of North 
Carolina’s Institutional Review Board.  Data were collected between September 20, 2011 and 
November 7, 2014. 
 
The lifestyle study consisted of three phases, depicted in Figure 1.  Phase I focused on improving 
diet quality and increasing physical activity; this phase lasted 6 months and was the same for all 
study participants.  Phase II consisted of 1) a weight loss intervention for participants with a 
body mass index (BMI) ≥ 25 kg/m2 who chose to enroll in that arm and 2) a maintenance of 
lifestyle intervention for participants with a BMI < 25 kg/m
2
 and those who declined the weight 
loss intervention.  Phase II also lasted 6 months and immediately followed Phase I.  Phase III 
included 1) a year-long, randomized controlled trial comparing a more intensive and less 
intensive maintenance of weight loss intervention for participants who took part in the Phase II 
weight loss intervention and lost at least 8 lbs and 2) a year-long maintenance of lifestyle 
intervention for all other participants.  Prior randomized trials from our group
23-26
 have shown 
that similar formats of lifestyle and weight loss interventions are effective among low 
socioeconomic status participants, therefore, we opted not to include a control group for Phases I 
and II.  Furthermore, the community advisory committee strongly encouraged a study design in 
which all participants received “active treatment.” 
 
Participants 
The goal enrollment was 350 participants based on having an adequate sample for the embedded 
Phase III maintenance of weight loss randomized trial, as previously described.
19
  About 150 
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participants were recruited from the community and 200 were recruited from the high blood 
pressure study.  High blood pressure study participants were included because of their increased 
risk for CVD and thus potential to benefit from improved lifestyle behaviors.  Participants from 
the community were recruited through flyers, newspaper articles, television notices, word of 
mouth, and the study website.  The study’s screening inclusion criteria were relatively limited in 
an effort to enroll a representative sample.  The criteria were: age ≥ 18 years and interest in 
improving lifestyle behaviors to reduce cardiovascular disease risk.  Screening inclusion criteria 
for the high blood pressure study were age ≥ 18, being an established patient at a participating 
practice, and systolic BP ≥ 150 mmHg when assessed during routine care within the prior 12 
months.  Participants attending the enrollment visit for the high blood pressure study were 
invited to also take part in the lifestyle study until 200 agreed to do so.  
 
After obtaining verbal informed consent, research staff conducted phone interviews to screen 
potential participants, as previously described.
19
  If eligibility criteria were met, participants were 
invited to attend an enrollment visit at a central research office or at participating clinics.  
Written informed consent was obtained prior to collecting baseline measures.  Participants were 
compensated monetarily at each of the enrollment, 6, 12, and 24 month visits, receiving a total of 
$120 if they attended all visits. 
 
Phase I – Lifestyle Intervention 
The lifestyle intervention used in this study is a modification of a previously developed and 
tested intervention originally developed by Ammerman and colleagues,
27,28
 which was 
subsequently revised to emphasize carbohydrate quality as an important component of a heart 
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healthy diet.
23
  Consistent with the evolving literature suggesting regular consumption of foods 
with high quality fats is also important in reducing the risk of CVD in those with and without 
diabetes,
16,29-34
 this study’s dietary intervention was further modified to include a major focus on 
improving dietary fat quality as well.  These changes rendered the HHLP lifestyle intervention 
dietary pattern very similar to the PREDIMED study’s nut intervention arm diet;16 therefore, 
HHLP named the dietary pattern the “Med-South diet” because of its intended use in the 
Southeastern United States. 
 
The intervention format and content have been previously published and described in detail.
19
  
Phase I included four monthly sessions delivered by a trained counselor administered as hour-
long individual counseling sessions or two-hour-long group sessions which were held in the 
central research office or participating clinics.  Participants chose their preferred counseling 
format.  Intervention content and time was largely dedicated to dietary counseling (75%) and the 
rest (25%) physical activity counseling.  Dietary counseling focused on using culturally-relevant 
content to improve fat quality (such as increasing consumption of nuts, full-fat mayonnaise, and 
vegetable oils); increase fruit and vegetable consumption; favor fish and poultry to red and 
processed meats; and minimize sugar-sweetened beverages, desserts, and snacks.  Physical 
activity counseling recommended a goal of at least 7500 steps per day or at least 30 minutes of 
physical activity at least five days per week.  Spouses and friends were also invited to join the 
counseling intervention sessions.  When participants could not physically attend counseling 
sessions, telephone counseling was offered.  Participants also received a pedometer and activity 
logs to self-monitor physical activity as well as a listing of local community resources for 
healthy eating and physical activity.  Those participants who were co-enrolled in the high blood 
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pressure study also received a home blood pressure monitor and were instructed to measure their 
blood pressure at least three times per week.  Other interventions included in the high blood 
pressure study were not initiated during Phase I of the lifestyle study for the vast majority of 
participants who were dually enrolled. 
 
During counseling sessions, participants received dietary counseling and created an individually-
tailored action plan with his or her counselor to guide eating behaviors.  Dietary tips were given 
relevant to identified problematic eating behaviors, including recipe suggestions in a Southern-
style cookbook that was given to all participants.  Time permitting, physical activity was 
addressed at each session.  At the beginning of Sessions 2-4, the counselor and participants 
reviewed progress made toward previously stated goals. 
 
Phase II – Weight Loss and Maintenance of Lifestyle Intervention 
Participants with a BMI ≥ 25 kg/m2 could choose to take part in a weight loss intervention during 
the second phase of the HHLP lifestyle study.  Those who were not eligible for the weight loss 
intervention (BMI < 25 kg/m
2
) and those who declined the intervention received a maintenance 
of lifestyle intervention consisting of three phone calls, as previously described.
19
  Participants 
who elected to be in the weight loss intervention arm could choose between two formats: a 
previously-tested weekly group session format over 16 weeks or five group sessions with ten 
phone contacts (combination intervention), also over 16 weeks. 
 
Phase III – Maintenance of Weight Loss and Lifestyle Interventions 
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Participants who took part in the Phase II weight loss intervention and lost at least 8 lbs could 
choose to take part in a maintenance of weight loss randomized controlled trial (RCT).  All other 
study participants received brief, quarterly maintenance of lifestyle intervention phone calls 
(similar to Phase II), as previously described.
19
  For the maintenance of weight loss RCT, 
participants were randomized 1:1 to receive either 36 phone contacts (24 weekly calls over 6 
months followed by 12 biweekly calls over 6 months; more intensive intervention) or 18 phone 
contacts (12 biweekly calls over 6 months followed by 6 monthly calls over 6 months; less 
intensive intervention). 
 
Measures 
Outcome measures were assessed at baseline, 6, 12, and 24 months.  Previously validated 
questionnaires were administered including the Dietary Risk Assessment (DRA) which addresses 
overall diet quality,
27,35
 SF-12 (SF-12 instrument, Quality Metric, Inc., Lincoln, RI) which 
addresses quality of life, in addition to other assessments of fruit and vegetable intake,
36
 dietary 
fat quality,
37
 and physical activity.
38,39
  Physiologic measures included blood pressure, total 
cholesterol, HDL, hemoglobin A1c, blood carotenoids, and weight.  Weight was calculated as 
the average of two measures to the closest tenth pound according to an electronic scale.  Height 
was measured with a portable stadiometer at baseline only to calculate body mass index (BMI).  
Blood pressure was calculated as the average of three measurements which were recorded at 60 
second intervals (Omron HEM-907XL, Omron Healthcare, Lake Forest, IL) after being seating 
for five minutes.  Participants were asked about any adverse events at each follow-up visit. 
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Statistical analysis 
The HHLP lifestyle study size of 350 (based on powering the Phase III RCT) was considered 
sufficient for the primary descriptive outcome of changes in diet quality at 6 months and the 
secondary descriptive outcome of changes in diet quality and weight at 12 and 24 months follow-
up.  
 
Sample characteristics were summarized using descriptive statistics, with subgroups by diabetes 
status and race.  Outcomes were assessed using pre-post changes by diabetes status and race 
using paired t-tests for continuous outcomes, McNemar’s tests for binary outcomes, and Chi-
squared tests for subgroup analysis when appropriate.  Change in weight and percentage of 
participants who achieved greater than 5% weight loss were also analyzed by diabetes status and 
then by race within diabetes status.  In addition, changes in weight-related outcomes were further 
analyzed by intervention group; however, the RCT was ultimately underpowered so trends are 
shown without significance levels.  Because age, race, sex, education, and baseline weight are 
potential confounders for weight loss according to the literature, a linear regression model was 
performed adjusting for these variables.  Finally, questionnaires were administered at the end of 
each study phase to assess acceptability of the intervention; results were again summarized using 
descriptive statistics.  Participants who became pregnant, had bariatric surgery, or were 
diagnosed with cancer (excluding non-melanoma skin cancer or localized breast or prostate 
cancer diagnosed by screening tests) were excluded from analysis.  SAS version 9.3 was used for 
analysis. 
 
 
13 
 
Results 
Baseline Characteristics 
Participants’ baseline characteristics, by diabetes status then further categorized by race, are 
outlined in Table 1.  More than one third of study participants had diabetes.  The overall average 
age was 56 years; participants with diabetes were older on average than those without diabetes 
(59 versus 54 years) and white participants slightly older than black participants (58 versus 54 
years).  Men, particularly black men, were underrepresented in the sample.  More than half of 
participants did not have any college education; participants with diabetes and black participants 
were less educated on average than those without diabetes and white participants.  Those without 
diabetes and whites were also more likely to be married or living with a partner compared to 
others.  Most participants had health insurance (74%) and this did not appear to vary by diabetes 
status or race.  People with diabetes were more likely to not work due to health reasons (31% 
versus 14%) and less likely to be currently employed (34% versus 58%).  Black participants 
were slightly more likely to be currently employed than white participants regardless of diabetes 
status, though white participants reported higher household incomes on average compared to 
black participants.  Median household income was less than $40,000 overall; less than $20,000 
among participants with diabetes.   
 
In terms of cardiovascular risk factors, reported rates of hypertension were very high in the study 
(86% overall), which may be largely attributed to how participants were selected.  Participants 
with diabetes were more likely to report a history of hypertension (98% compared to 79%); and 
blacks reported higher rates of hypertension than whites within each subgroup.  Participants with 
diabetes also reported higher rates of prior coronary heart disease and cardiovascular disease; 
14 
 
there were no apparent differences between races.  The majority of study participants had high 
cholesterol at baseline (56%); participants with diabetes were more likely to have high 
cholesterol (67% versus 49%) and whites were more likely to have high cholesterol than blacks, 
particularly among those without diabetes (63% versus 42%).  There was no apparent variation 
in smoking by diabetes status or race.   
 
At baseline, overall diet quality and fat quality were similar across diabetes status and race, with 
an average DRA total score of 27.8 and fat quality screener score of 15.5.  Participants with 
diabetes had slightly higher fruit and vegetable consumption at baseline (average 3.7 servings per 
day compared to 3.3).  Within that subgroup, blacks reported slightly higher fruit and vegetable 
consumption (3.8 versus 3.3) though whites reported higher fruit and vegetable consumption 
among participants without diabetes (3.5 versus 3.1).  Participants without diabetes reported 
much higher total walking and total activity time at baseline (mean 105 and 171 minutes per 
week, respectively, compared to 67 and 112 minutes per week among those with diabetes).  
Black participants reported longer walking times than whites at baseline within each diabetes 
status subgroup though there was less of a difference between races for total activity time. 
Participants with diabetes weighed more on average than those without diabetes at baseline (103 
kg compared to 95 kg).  Among participants without diabetes, blacks weighed more than whites 
at baseline (99 kg versus 90 kg); there was no difference in weight between races among 
participants with diabetes.  BMI is similarly reflective of this trend with an average BMI of 38 
among participants with diabetes, regardless of race, and an average of 37 among black 
participants without diabetes and 32 for white participants without diabetes.  Systolic blood 
pressure was similar across all categories, with a slightly higher average for blacks than whites 
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(138 mmHg compared to 131 mmHg) among participants with diabetes.  Among those with 
diabetes, black participants had higher hemoglobin A1c percentage at baseline than whites (8.0 
compared to 7.6).  There was no difference between races among those without diabetes.  
Participants with diabetes had lower total cholesterol levels at baseline (188 mg/dL compared to 
196 mg/dL), with HDL slightly lower (51 mg/dL versus 56 mg/dL) for those without diabetes.  
Black participants had slightly higher HDL levels (55 mg/dL versus 43 mg/dL among those with 
diabetes) and lower total cholesterol levels among those without diabetes (193 mg/dL compared 
to 200 mg/dL).   
 
Outcomes 
Several lifestyle and physiologic outcomes of interest were assessed at baseline and at the end of 
each of the three study phases (6 months, 12 months, and 24 months).  Follow-up rates are 
outlined in Figure 1 with approximately 75% follow-up after each of the three phases.  Follow-
up rates were similar between participants with and without diabetes. 
 
Lifestyle outcomes (Table 2) revealed that DRA total score was 4 points higher, representing 
better diet quality, at 6 months among all subgroups, which was statistically significant.  
Improvement in DRA total score was maintained at 12 months and 24 months compared to 
baseline among all subgroups except white participants with diabetes. Fat quality score improved 
by 1.4 on average at 6 months with no significant difference between subgroups by race or 
diabetes status.  Improvement in fat quality was sustained at 12 and 24 months but only 
statistically significant among the subgroups with larger sample sizes.  Only participants without 
diabetes reported a statistically significant increase in fruit and vegetable servings per day at 6 
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month, 12 month, and 24 month follow-up.  Summary score for drinks, desserts, and snacks was 
higher among black participants with and without diabetes. 
 
An increase in walking time was sustained at 24 months only among participants with diabetes, 
and black participants demonstrated a greater increase in walking than whites within that 
subgroup.  This was also true for total activity time where black participants with diabetes were 
the only subgroup to demonstrate significantly increased activity time compared to baseline at 24 
months.   
 
Several measured physiologic outcomes (Table 3) also improved over the course of the study.  
Among participants with diabetes, systolic blood pressure was reduced by an average of 6 
mmHg at 6 months.  This finding was sustained at 24 months with an average drop in systolic 
blood pressure of 7 mmHg among participants with diabetes.  The improvement in systolic blood 
pressure among participants with diabetes can be largely attributed to the black subpopulation of 
participants as whites did not demonstrate the same improvement in systolic blood pressure (-
0.39 mmHg at 24 months) compared to blacks (-9.29 mmHg at 24 months).  There was a similar 
trend with improvement in diastolic blood pressure over the course of the study.  On average, 
both participants with and without diabetes demonstrated improvements in diastolic blood 
pressure (-7.18 mmHg at 24 months for participants with diabetes and -6.44 mmHg at 24 months 
for participants without diabetes).  Improvements in blood pressure were approximately equal 
across races among participants without diabetes however among participants with diabetes, 
black participants again had greater change in diastolic blood pressure compared to baseline on 
average than white participants (-8.18 mmHg which was a statistically significant drop compared 
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to -3.33 which was not statistically significant, respectively).  There is a trend toward significant 
improvement in hemoglobin A1c at 12 months among participants with diabetes (-0.30; p=0.07). 
Weight loss was a major outcome of interest.  Participants with diabetes had significant, 
sustained, and progressive weight loss compared to baseline at 6, 12, and 24 months (mean -1.24 
kg, -1.53 kg, and -3.67 kg respectively) across all intervention groups.  White participants with 
diabetes appear to have greater weight loss than black participants with diabetes however their 
weight loss only reached statistical significance at 24 months given the small sample size.  Black 
participants with diabetes appeared to lose the most weight during phase III of the study.  
Participants with diabetes showed greater weight loss than those without diabetes as participants 
without diabetes did not have sustained weight loss at 24 months on average, despite showing 
significant weight loss at 12 months. Sample sizes are too small to provide informative statistics 
by intervention group though weight loss was similar across intervention groups at 24 months.
19
  
 
After adjusting for age, race, sex, education, and baseline weight, our regression model 
demonstrated that only participants with diabetes had significant, sustained weight loss at 24 
months (p<0.0001) and that participants with diabetes had significantly more weight loss on 
average than participants without diabetes (p=0.01). 
 
In addition to measuring average change in absolute weight from baseline, success of the 
intervention was also measured by calculating percentage of participants who achieved greater 
than five percent weight loss compared to baseline at each time point.  Again, a greater 
proportion of participants with diabetes demonstrated sustained, >5% weight loss compared to 
baseline at 24 months compared to those without diabetes (34.4% compared to 16.23%, 
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respectively).  Percentages were similar between blacks and whites with diabetes however more 
black participants without diabetes achieved >5% weight loss at 24 months than whites without 
diabetes (18.5% compared to 10.0%, respectively). 
 
Acceptability of the interventions was assessed using questionnaires at the end of each study 
phase.  At the end of the lifestyle intervention (Phase I), the majority of participants, regardless 
of diabetes status or race, felt that the session on nuts, spreads, dressings, and oils was most 
helpful.  The vast majority of participants with and without diabetes either “strongly agreed” or 
“agreed” that the lifestyle intervention was easy to understand.  More participants without 
diabetes “strongly agreed” that the lifestyle program was easy to understand (65%; compared to 
43% with diabetes). Almost all (97%) of participants with diabetes and (98%) without diabetes 
either strongly agreed or agreed that they would recommend the lifestyle program to others.  
After Phase II, all participants with diabetes in the group weight loss arm were satisfied or very 
satisfied with the intervention and 88% of participants with diabetes in the combination weight 
loss arm were satisfied or very satisfied with the intervention.  Participants without diabetes were 
similarly satisfied with the interventions. 
 
Discussion 
The HHLP lifestyle study promotes a Mediterranean-style diet with a focus on fat and 
carbohydrate quality in a way that is designed to be appealing to residents of the Southeastern 
United States, particularly in the “stroke belt” where the population’s cardiovascular risk is very 
high.  Though this type of dietary intervention has been validated in Europe, it has not been well-
studied in the United States, particularly in low-income, high-risk, minority populations.  The 
19 
 
lifestyle and weight loss interventions in our study led to improved reported overall diet quality, 
fat quality, fruit and vegetable consumption; and improved observed blood pressure and weight 
loss, though some subgroups of participants across diabetes status and race appeared to benefit 
more than others.  The sustained weight loss among participants with diabetes at 24 months (3.67 
kg) was the most noteworthy outcome.  Participants with diabetes may have been more 
motivated to lose weight than those without diabetes.   
 
The PREDIMED study documented efficacy of a similar dietary intervention however African 
Americans were not well represented in that study.  PREDIMED study participants were 97% 
white.  Because of the socioeconomic make-up of Lenoir County, residents have unique 
challenges compared to a largely European cohort.  Despite these challenges, our tailored 
intervention led to improved cardiovascular intermediate outcomes such as reduced blood 
pressure, increased physical activity, improved diet quality, as well as weight loss. 
 
Our intervention did not achieve the same degree of weight loss documented in the Diabetes 
Prevention Program (DPP) study,
18
 which was over 5 kg at 24 months; however the study 
populations were very different.  All participants in DPP were enrolled in an intensive weight 
loss intervention whereas fewer than half of participants in the HHLP lifestyle study opted to 
participate in the weight loss intervention.  DPP also had more selective inclusion criteria and 
more exclusion criteria than HHLP.  Furthermore, DPP enrolled participants without diabetes 
who had lower baseline weight; other studies have shown that individuals with higher BMI have 
more difficulty losing weight.
24,40,41
  Incidentally, white participants with diabetes in the HHLP 
study still achieved similar weight loss (5.5 kg at 24 months) despite these differences.  In fact, a 
20 
 
meta-analysis of weight loss interventions among individuals with diabetes shows that the 
average weight loss using lifestyle interventions is much less than 3.7 kg at 24 months.
14
  
Unfortunately race data are not available as part of the meta-analysis however other studies have 
documented that whites tend to lose more weight on average than blacks with lifestyle 
interventions.
42
   
 
Older participants and women are more likely to succeed with this type of counseling-based 
intervention format
43
 and the study population is largely older women.  Though we cannot 
account for all differences in baseline characteristics, a regression model adjusting for age, race, 
sex, education, and baseline weight did not show materially different outcomes compared to our 
unadjusted results. 
 
The main limitation of the study is the lack of control group.  Observed changes may be due to 
the intervention, by also may be due to secular trends.  However, in the control groups of the 
DPP and Look AHEAD RCTs, weight loss at 2 years, on average, was less than one 
kilogram
15,18
 suggesting that the weight loss is likely due to the intervention.  In addition, from 
2011 to 2014, there was no change in rates of overweight and obesity as assessed by the CDC’s 
behavioral risk factor surveillance system.
44
   Another limitation is that lifestyle outcomes were 
self-reported and may have been exaggerated due to social desirability reporting bias.   
 
Strengths of the study include its unselected sample with few exclusion criteria which enhances 
its generalizability.  Furthermore, the fact that participants could choose their study arm allowed 
the study to mimic a real-world situation.  The study enrolled over 300 participants with 74% 
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follow-up at 24 months, which is longer follow-up than most weight loss studies, with a 
substantial percentage of patients with diabetes.  Physiologic outcomes were obtained using 
standardized objective measures.  Finally, the weight loss observed in this study was more than 
most studies with 24 month follow-up.
14
 
 
Conclusions 
Although the majority of participants did not choose to participate in the weight loss intervention 
arm of the study, participants with diabetes across intervention arms achieved a sustained 3.67 kg 
weight loss at 24 months, as well as improved blood pressure, physical activity, diet quality, and 
a strong trend toward improvement in hemoglobin A1c.  This study shows promise for a lifestyle 
intervention to improve cardiovascular risk, particularly among participants with diabetes, in a 
high-risk region of the United States.  Therefore, further study is warranted with a randomized 
controlled trial to assess the benefits of this Mediterranean diet-based lifestyle intervention in 
high-risk populations. 
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Phase I:  Lifestyle Program; n=291 
Baseline Measures 
n=339 (n=124)* 
6 Month Measures 
n=249; 73% (n=93; 75%) 
 
N 
Phase II:  Participants with BMI ≥ 25 kg/m
2
 offered 
                weight loss intervention; n=298 
12 Month Measures 
n=253; 75% (n=98; 79%) 
Phase III:  Participants in weight loss program who lost ≥ 8 lbs offered 
RCT (randomized controlled trial) of Weight Loss Maintenance; 
others continued with Maintenance of Lifestyle; n=285 
RCT 
 Weight Loss 
Maintenance 
n=27; 9% 
 
Maintenance 
 of Lifestyle 
n=258; 91% 
24 Month Measures 
n=250; 74% (n=96; 77%) 
 Intensive Maintenance 
n=15; 56% 
 Standard Maintenance 
n=12; 44% 
Fig. 1 Study overview 
*Numbers in parentheses represent participants with diabetes and their respective follow-up rates at the end of each 
study phase. 
Weight Loss Program 
n=138; 46% 
Maintenance of Lifestyle 
n=160; 54% 
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Table 1. Baseline Characteristics: Overall, by Diabetes Status then by Race 
 
 Overall  Diabetes   No 
Diabetes 
 
Characteristics  All Black White All Black White 
 n=339 n=124 n=89 n=34 n=215 n=130 n=83 
Demographics        
Age, mean (SE) 56 (0.6) 59 (0.9) 59 (1.1) 61 (1.7) 54 (0.8) 51 (1.1) 57 (1.2) 
Female 260 (77) 93 (75) 70 (79) 22 (65) 167 (78) 111 (85) 54 (65) 
Race        
--Black 219 (65) 89 (72)   130 (60)   
--White 117 (35) 34 (27)   83 (39)   
Education, years        
-- ≤ 8 (middle school or less) 16 (5) 7 (6) 4 (5) 3 (9) 9 (4) 7 (5) 2 (2) 
-- 9-11 (some high school) 45 (13) 25 (20) 22 (25) 2 (6) 20 (9) 13 (10) 7 (8) 
-- 12 (high school graduate) 128 (38) 46 (37) 36 (40) 10 (29) 82 (38) 58 (45) 24 (29) 
-- 13-15 (some college) 79 (23) 24 (19) 16 (18) 8 (24) 55 (26) 29 (22) 25 (30) 
-- 16 (college graduate) 49 (14) 14 (11) 9 (10) 5 (15) 35 (16) 17 (13) 17 (21) 
-- > 16 (graduate school) 22 (7) 8 (7) 2 (2) 6 (18) 14 (7) 6 (5) 8 (10) 
Education: high school or less 189 (56) 78 (63) 62 (70) 15 (44) 111 (52) 78 (60) 33 (40) 
Marital status        
-- Married or living with a partner 159 (47) 51 (41) 32 (36) 19 (56) 108 (50) 50 (39) 57 (69) 
-- Other 180 (53) 73 (59) 57 (64) 15 (44) 107 (50) 80 (62) 26 (31) 
Currently have health insurance 251 (74) 94 (76) 68 (76) 25 (74) 157 (73) 88 (68) 67 (81) 
Current employment        
-- Working full-time 124 (37) 25 (20) 18 (20) 7 (21) 99 (46) 64 (49) 33 (40) 
-- Working part-time 42 (12) 17 (14) 14 (16) 2 (6) 25 (12) 17 (13) 8 (10) 
-- Do not work due to health reasons 69 (20) 38 (31) 26 (29) 12 (35) 31 (14) 17 (13) 14 (17) 
-- Retired 53 (16) 26 (21) 18 (20) 8 (24) 27 (13) 8 (6) 19 (23) 
-- Other 51 (15) 18 (15) 13 (15) 5 (15) 33 (15) 14 (19) 9 (11) 
Annual household income        
-- < $10,000 62 (20) 31 (29) 24 (32) 6 (18) 31 (14) 26 (22) 5 (7) 
-- $10,000 to < $20,000 64 (21) 28 (26) 23 (31) 5 (15) 36 (17) 22 (19) 14 (18) 
-- $20,000 to < $40,000 84 (28) 29 (27) 20 (27) 9 (27) 55 (26) 40 (34) 14 (18) 
-- $40,000 to < $60,000 33 (11) 9 (8) 3 (4) 6 (18) 24 (11) 12 (10) 12 (16) 
-- $60,000 to < $80,000 27 (9) 9 (8) 4 (5) 5 (15) 18 (8) 9 (8) 9 (12) 
-- ≥ $80,000 34 (11) 2 (2) 0 (0) 2 (6) 32 (15) 10 (8) 22 (29) 
        
CVD and risk factors for CVD        
Known coronary heart disease 49 (14) 28 (23) 20 (23) 8 (24) 21 (10) 10 (8) 11 (13) 
Known cardiovascular disease 62 (18) 33 (27) 23 (26) 10 (29) 29 (13) 14 (11) 15 (18) 
Hypertension 291 (86) 121 (98) 88 (99) 32 (94) 170 (79) 107 (82) 63 (76) 
Cholesterol         
-- High (≥240 mg/dL) 187 (56) 82 (67) 57 (65) 24 (71) 105 (49) 53 (42) 52 (63) 
-- Borderline (200-239 mg/dL) 46 (14) 8 (7) 7 (8) 1 (3) 38 (18) 26 (21) 11 (13) 
-- Desirable (<200 mg/dL) 102 (30) 33 (27) 24 (27) 9 (27) 69 (32) 48 (38) 20 (24) 
Diabetes 124 (37)       
Current cigarette smoker 54 (16) 21 (17) 17 (19) 4 (12) 33 (15) 20 (15) 13 (16) 
Packs of cigarettes smoked per day, 
mean (SE) for current smokers 
0.7 (0.1) 0.6 (0.1) 0.6 (0.1) 0.8 (0.2) 0.7 (0.1) 0.6 (0.1) 0.9 (0.2) 
Taking BP lowering medications 260 (77) 114 (92) 83 (93) 30 (88) 146 (68) 93 (72) 53 (64) 
 
 
 
       
27 
 
Lifestyle*        
DRA total score 27.8 (0.3) 28.5 (0.5) 28.3 (0.6) 28.9 (0.7) 27.4 (0.4) 27.2 (0.5) 27.7 (0.7) 
Fat quality screener score 15.5 (0.2) 15.5 (0.2) 15.4 (0.3) 15.7 (0.3) 15.4 (0.2) 15.3 (0.2) 15.7 (0.4) 
Fruit and vegetable servings per day 3.4 (0.1) 3.7 (0.2) 3.8 (0.2) 3.3 (0.3) 3.3 (0.1) 3.1 (0.2) 3.5 (0.2) 
Walking time (min/wk) 91 (11.3) 67 (12.8) 68 (15.6) 54 (20.5) 105 (16.1) 122 (24.9) 80 (14.3) 
Activity time (min/wk) 149 (14.0) 112 (18.1) 112 (20.5) 99 (36.0) 171 (19.3) 176 (27.1) 161 (26.3) 
        
Physiologic*        
Weight, kg 98 (1.4) 103 (2.2) 103 (2.4) 104 (4.7) 95 (1.7) 99 (2.3) 90 (2.5) 
BMI 36 (0.5) 38 (0.8) 38 (0.9) 38 (1.6) 35 (0.7) 37 (0.9) 32 (0.9) 
Systolic blood pressure, mmHg 135 (1.2) 136 (2.0) 138 (2.4) 131 (3.6) 134 (1.5) 136 (2.1) 133 (2.2) 
Diastolic blood pressure, mmHg 82 (0.7) 81 (1.1) 82 (1.4) 78 (1.9) 83 (0.8) 84 (1.1) 81 (1.2) 
Hemoglobin A1c, % 6.6 (0.1) 7.9 (0.2) 8.0 (0.2) 7.6 (0.3) 5.8 (0.0) 5.8 (0.0) 5.7 (0.0) 
Total cholesterol, mg/dL 193 (2.3) 188 (4.1) 188 (5.0) 187 (7.2) 196 (2.7) 193 (3.2) 200 (4.8) 
HDL cholesterol, mg/dL 54 (0.8) 51 (1.4) 55 (1.6) 43 (2.1) 56 (1.0) 58 (1.3) 53 (1.6) 
 
*mean (SE) recorded unless otherwise noted 
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Table 2. Change in Lifestyle Outcomes from Baseline to 6, 12, and 24 months 
  
  Phase 1  Phase 2  Phase 3 
Outcome  Baseline to 6 months  Baseline to 12 months  Baseline to 24 months 
 n Mean, 95% CI n Mean, 95% CI n Mean, 95% CI 
Dietary       
       
DRA total score 235 4.35 (3.68, 5.02)
a
 227 3.28 (2.54, 4.02)
a
 226 2.95 (2.28, 3.61)
a
 
  Diabetes (all) 86 4.19 (3.05, 5.33)
a
 86 3.04 (1.84, 4.24)
a
 84 2.03 (0.98, 3.09)
b
 
  --Black 60 4.41 (2.88, 5.94)
a
 63 3.80 (2.30, 5.31)
a
 62 2.46 (1.20, 3.72)
b
 
  --White 25 4.00 (2.63, 5.37)
a
 22 1.09 (-0.57, 2.75) 21 0.71 (-1.29, 2.72) 
  No diabetes (all) 149 4.43 (3.61, 5.26)
a
 141 3.42 (2.48, 4.37)
a
 142 3.49 (2.65, 4.32)
a
 
  --Black 95 4.72 (3.70, 5.74)
a
 93 4.14 (3.01, 5.26)
a
 96 3.34 (2.25, 4.42)
a
 
  --White 52 3.93 (2.47, 5.39)
a
 47 2.02 (0.31, 3.74)
d
 45 3.74 (2.48, 5.00)
a
 
       
Fat quality screener 
score 
229 1.39 (0.13, 1.75)
a
 225 0.97 (0.62, 1.32)
a
 224 0.66 (0.27, 1.05)
b
 
  Diabetes (all) 84 1.32 (0.67, 1.98)
a
 85 1.21 (0.64, 1.78)
a
 83 0.34 (-0.29, 0.96) 
  --Black 58 1.19 (0.36, 2.02)
c
 62 1.50 (0.77, 2.23)
a
 61 0.39 (-0.34, 1.12) 
  --White 25 1.56 (0.43, 2.69)
c
 22 0.41 (-0.34, 1.15) 21 0.14 (-1.19, 1.48) 
  No diabetes (all) 145 1.43 (1.00, 1.86)
a
 140 0.83 (0.39, 1.27)
b
 141 0.84 (0.35, 1.34)
b
 
  --Black 92 1.51 (0.98, 2.05)
a
 92 1.07 (0.55, 1.58)
a
 95 0.84 (0.28, 1.40)
c
 
  --White 51 1.24 (0.50, 1.97)
c
 47 0.40 (-0.43, 1.24) 45 0.87 (-0.14, 1.87) 
       
Fruit and vegetable 
servings per day 
249 0.29 (0.06, 0.51)
d
 253 0.54 (0.28, 0.80)
a
 250 0.38 (0.16, 0.61)
b
 
  Diabetes (all) 93 -0.06 (-0.50, 0.38) 98 0.18 (-0.30, 0.66) 96 0.05 (-0.35, 0.45) 
  --Black 67 -0.14 (-0.72, 0.45) 75 0.22 (-0.38, 0.83) 74 0.06 (-0.44, 0.55) 
  --White 25 0.13 (-0.38, 0.65) 22 -0.03 (-0.64, 0.57) 21 0.05 (-0.63, 0.73) 
  No diabetes (all) 156 0.49 (0.25, 0.74)
a
 155 0.76 (0.47, 1.05)
a
 154 0.59 (0.33, 0.86)
a
 
  --Black 101 0.51 (0.21, 0.82)
c
 103 0.76 (0.38, 1.14)
a
 103 0.56 (0.21, 0.90)
c
 
  --White 53 0.45 (0.02, 0.88)
d
 51 0.76 (0.33, 1.20)
b
 50 0.64 (0.23, 1.06)
c
 
       
Summary score for 
drinks, desserts, 
snacks 
236 1.10 (0.85, 1.34)
a
 229 1.34 (1.07, 1.61)
a
 228 1.08 (0.82, 1.33)
a
 
  Diabetes (all) 87 1.06 (0.71, 1.40)
a
 87 1.18 (0.79, 1.58)
a
 85 0.92 (0.53, 1.31)
a
 
  --Black 61 1.11 (0.67, 1.56)
a
 64 1.25 (0.77, 1.73)
a
 63 1.14 (0.71, 1.57)
a
 
  --White 25 1.00 (0.48, 1.52)
b
 22 1.05 (0.31, 1.78)
c
 21 0.14 (-0.68, 0.97) 
  No diabetes (all) 149 1.12 (0.79, 1.46)
a
 142 1.43 (1.07, 1.79)
a
 143 1.17 (0.83, 1.51)
a
 
  --Black 95 1.33 (0.89, 1.76)
a
 93 1.66 (1.18, 2.14)
a
 96 1.32 (0.88, 1.76)
a
 
  --White 52 0.71 (0.20, 1.22)
c
 48 0.92 (0.43, 1.41)
b
 46 0.78 (0.31, 1.26)
c
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Physical Activity       
       
Walking time, 
min/wk 
249 64.17 (19.23, 109.12)
c
 253 70.75 (28.36, 113.15)
c
 250 21.76 (-12.72, 56.23) 
  Diabetes (all) 93 100.69 (16.90, 184.47)
d
 98 126.00 (57.57, 194.43)
b
 96 61.90 (10.71, 113.08)
d
 
  --Black 67 119.31 (17.52, 221.11)
d
 75 135.77 (51.72, 219.83)
c
 74 74.91 (12.52, 137.29)
d
 
  --White 25 70.80 (-81.24, 222.84) 22 116.59 (14.15, 219.04)
d
 21 38.05 (-36.18, 112.27) 
  No diabetes (all) 156 42.40 (-8.78, 93.59) 155 35.82 (-17.44, 89.08) 154 -3.27 (-48.79, 42.26) 
  --Black 101 28.81 (-44.88, 102.50) 103 18.70 (-53.49, 90.88) 103 -17.26 (-81.99, 47.47) 
  --White 53 63.11 (7.89, 118.33)
d
 51 67.57 (-3.24, 138.38) 50 21.90 (-21.87, 65.67) 
       
Activity time, 
min/wk 
249 96.76 (35.65, 157.87)
c
 253 83.03 (30.21, 135.85)
c
 250 48.09 (-7.12, 103.29) 
  Diabetes (all) 93 120.25 (19.24, 221.26)
d
 98 108.51 (28.95, 188.07)
c
 96 61.67 (-8.09, 131.42) 
  --Black 67 135.72 (16.81, 254.62)
d
 75 127.32 (32.04, 222.60)
c
 74 88.80 (2.76, 174.83)
d
 
  --White 25 105.60 (-94.27, 305.47) 22 74.32 (-63.00, 211.64) 21 -4.81 (-90.53, 80.91) 
  No diabetes (all) 156 82.76 (6.10, 159.41)
d
 155 66.92 (-2.97, 136.81) 154 39.62 (-38.70, 117.95) 
  --Black 101 85.89 (-17.24, 189.03) 103 36.97 (-41.94, 115.88) 103 28.27 (-75.52, 132.06) 
  --White 53 79.34 (-32.89, 191.57) 51 125.18 (-15.11, 265.46) 50 57.80 (-55.44, 171.04) 
       
 
a
 p≤0.0001 
b p≤0.001 
c 
p<0.01 
d 
p<0.05 
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Table 3. Change in Physiologic Outcomes from Baseline to 6, 12, and 24 months  
  Phase 1  Phase 2  Phase 3 
  Baseline to 6 months  Baseline to 12 months  Baseline to 24 months 
Outcome n Mean, 95% CI n Mean, 95% CI n Mean, 95% CI 
       
Systolic BP, mmHg 249 -6.39 (-8.69, -4.09)
a
 251 -6.15 (-8.99, -3.31)
a
 250 -7.25 (-9.93, -4.57)
a
 
  Diabetes (all) 93 -7.14 (-11.28, -2.99)
b
 97 -5.75 (-10.93, -0.57)
d
 96 -7.44 (-11.92, -2.97)
c
 
  --Black 67 -8.58 (-13.93, -3.22)
c
 74 -6.39 (-12.69, -0.08)
d
 74 -9.29 (-14.57, -4.02)
b
 
  --White 25 -3.83 (-9.63, 1.98) 22 -4.11 (-13.19, 4.96) 21 -0.39 (-8.73, 7.95) 
  No diabetes (all) 156 -5.94 (-8.65, -3.24)
a
 154 -6.40 (-9.68, -3.11)
b
 154 -7.13 (-10.47, -3.79)
a
 
  --Black 101 -5.56 (-8.91, -2.21)
c
 102 -7.34 (-11.58, -3.10)
b
 103 -7.85 (-12.22, -3.49)
b
 
  --White 53 -6.45 (-11.26, -1.65)
c
 51 -4.31 (-9.46, 0.84) 50 -5.60 (-10.66, -0.54)
d
 
       
Diastolic BP, mmHg 249 -3.73 (-4.93, -2.53)
a
 251 -4.98 (-6.38, -3.57)
a
 250 -6.72 (-8.29, -5.15)
a
 
  Diabetes (all) 93 -4.36 (-6.40, -2.32)
a
 97 -5.61 (-8.19, -3.02)
a
 96 -7.18 (-10.10, -4.26)
a
 
  --Black 67 -4.63 (-7.17, -2.10)
b
 74 -5.77 (-8.81, -2.72)
b
 74 -8.18 (-11.70, -4.66)
a
 
  --White 25 -4.12 (-7.57, -0.67)
d
 22 -4.72 (-10.00, 0.56) 21 -3.33 (-8.30, 1.65) 
  No diabetes (all) 156 -3.35 (-4.82, -1.89)
a
 154 -4.58 (-6.19, -2.98)
a
 154 -6.44 (-8.21, -4.66)
a
 
  --Black 101 -2.82 (-4.76, -0.87)
c
 102 -4.81 (-6.95, -2.68)
a
 103 -6.47 (-8.91, -4.03)
a
 
  --White 53 -4.29 (-6.51, -2.07)
b
 51 -3.92 (-6.22, -1.63)
b
 50 -6.33 (-8.53, -4.14)
a
 
       
Weight, kg 248 -0.71 (-1.17, -0.26)
c
 250 -1.72 (-2.47, -0.96)
a
 247 -1.63 (-2.51, -0.75)
b
 
  Diabetes (all) 92 -1.24 (-2.10, -0.38)
c
 96 -1.53 (-2.89, -0.17)
d
 93 -3.67 (-5.19, -2.14)
a
 
  --Black 66 -1.13 (-1.96, -0.29)
c
 73 -1.03 (-2.45, 0.39) 71 -3.07 (-4.61, -1.52)
b
 
  --White 25 -1.64 (-3.95, 0.67) 22 -3.26 (-6.90, 0.38) 21 -5.53 (-9.85, -1.21)
d
 
  No diabetes (all) 156 -0.40 (-0.91, 0.11) 154 -1.83 (-2.71, -0.95)
a
 154 -0.40 (-1.42, 0.62) 
  --Black 101 -0.67 (-1.37, 0.04) 102 -2.23 (-3.37, -1.08)
b
 103 -0.94 (-2.24, 0.35) 
  --White 53 0.17 (-0.48, 0.81) 51 -0.96 (-2.29, 0.37) 50 0.86 (-0.76, 2.48) 
       
≥5% weight loss, % 248 9.27 (5.64, 12.91) 250 23.20 (17.93, 28.47) 247 23.08 (17.79, 28.37) 
  Diabetes (all) 92 10.87 (4.47, 17.27) 96 20.83 (12.65, 29.01) 93 34.41 (24.69, 44.13) 
  --Black 66 12.12 (4.10, 20.15) 73 19.18 (9.98, 28.38) 71 32.39 (21.30, 43.49) 
  --White 25 8.00 (0.00, 18.84) 22 27.27 (8.32, 46.23) 21 38.10 (16.93, 59.26) 
  No diabetes (all) 156 8.33 (3.97, 12.70) 154 24.68 (17.82, 31.53) 154 16.23 (10.37, 22.10) 
  --Black 101 11.88 (5.50, 18.26) 102 26.47 (17.81, 35.13) 103 18.45 (10.87, 26.02) 
  --White 53 1.89 (0.00, 5.59) 51 19.61 (8.59, 30.63) 50 10.00 (1.59, 18.41) 
       
HgA1c, % 217 0.01 (-0.09, 0.12) 220 -0.07 (-0.20, 0.06)   
  Diabetes (all) 80 -0.11 (-0.38, 0.17) 84 -0.30 (-0.63, 0.02)   
  --Black 60 -0.10 (-0.45, 0.25) 66 -0.33 (-0.72, 0.06)   
  --White 19 -0.20 (-0.60, 0.20) 17 -0.28 (-0.85, 0.28)   
  No diabetes (all) 137 0.08 (0.04, 0.11)
a
 136 0.07 (0.01, 0.13)
d
   
  --Black 87 0.10 (0.05, 0.14)
a
 88 0.08 (0.01, 0.16)
d
   
  --White 48 0.05 (0.00, 0.10) 47 0.05 (-0.03, 0.13)   
       
a
 p≤0.0001 
b p≤0.001 
c 
p<0.01 
d 
p<0.05 
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Literature Review: Does a Mediterranean Diet Reduce Cardiovascular Disease? 
 
Introduction 
Cardiovascular disease (CVD) is the leading cause of mortality in the United States
1
 and 
worldwide,
2
 and is therefore a major public health concern.  Although there are numerous factors 
that contribute to the incidence of CVD, diet has been long recognized as a modifiable risk 
factor.  From a public health perspective, prevention of CVD is the ideal approach to reduce 
deaths and nonfatal events such as myocardial infarctions (MI) and cerebrovascular accidents 
(CVA), or strokes.  Prevention is also crucial to curbing the unsustainable associated health care 
costs for interventions including hospitalizations, procedures, medications, and long-term care 
for debility after non-fatal CVD events.   
 
CVD is particularly prevalent in the Southeastern United States,
3
 much of which is aptly named 
the “stroke belt.”  Overall diet quality is poor in the stroke belt;4,5 access to healthy foods is a real 
problem in rural communities; and residents are more likely to be of low socioeconomic status, 
obese, sedentary, and African American.  All of these are risk factors for CVD.  Diet quality is a 
modifiable risk factor that contributes to obesity and diabetes which are stronger risk factors for 
CVD.  Prior studies have shown that lifestyle interventions can be effective in achieving weight 
loss and improving intermediate outcomes but few have demonstrated a reduction in 
cardiovascular events.
6,7
   
 
Historically, dietary recommendations including those from national organizations such as the 
American Heart Association have focused on reducing fat, particularly saturated fat, from the 
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diet.
8
  However, randomized controlled trials studying the effects of a low-fat diet on 
cardiovascular health have failed to show reduced CVD events.
6,7,9
  In fact, there is concern that 
promoting a low-fat diet may contribute to increased consumption of carbohydrates that may 
ultimately worsen rates of obesity and diabetes, and may increase the risk of CVD.
10
 
 
Some studies have promoted a Mediterranean diet.  Mediterranean diets have common features – 
an emphasis on vegetables, fruits, beans, nuts, seeds, breads, unrefined grains, and olive oil; 
inclusion of fish and wine; and minimal intake of meats and full-fat dairy products.
11
  The olive 
oil, nuts, and fatty fish would not be recommended as part of a strictly low-fat dietary pattern.  
Despite this, studies evaluating a Mediterranean-based diet seem to be the most promising in 
terms of reducing CVD,
12
 hence the question, “Does a Mediterranean diet reduce cardiovascular 
disease?” 
 
Methods 
Search Strategy 
An electronic search of PubMed and Google Scholar were used to identify relevant studies.  
PubMed was searched using the MeSH terms “Mediterranean diet” and “cardiovascular 
diseases.”  The search was supplemented by reviewing references from identified articles and 
reviews.  
 
Article Selection 
Selected articles were limited to those published in English, involving human subjects, and with 
full text availability.  The search was also narrowed to include only clinical studies or trials 
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(including randomized controlled trials and comparative studies).  Titles and abstracts were 
reviewed to confirm relevance to the question.  Specifically, studies needed to use a traditional 
Mediterranean diet and evaluate CVD outcomes (including cardiovascular death, MI, or CVA).  
Studies that assessed intermediate outcomes only (e.g. laboratory markers, blood pressure, lipid 
profiles, etc) were excluded.  Studies that used a modified Mediterranean diet were excluded.  
Titles that were clearly not relevant were excluded (e.g. looking at cancer outcomes in pts with 
high cardiovascular risk instead of cardiovascular outcomes).  If the relevance was unclear, 
abstracts were reviewed more thoroughly.  To narrow the search further, only articles that were 
published after 2006 underwent full text review for this limited literature review.  Articles that 
included a traditional Mediterranean diet and identified at least one cardiovascular outcome 
(including cardiac mortality, MI, CVA, congestive heart failure (CHF)) published after 2006 
underwent full text review.  If multiple studies were published by the same author group using 
the same data set from the same study or trial, only the main cardiovascular results paper was 
used instead of looking at smaller articles with more segmented samples and outcomes. 
 
Data Abstraction and Evaluation 
Articles were read for analytical consideration of the quality of findings, including strengths and 
limitations by a single author (GGRE) to assess internal and external validity.  Considerations 
included study design (e.g. randomized controlled trials were considered more favorable than 
observational studies), confounders, bias, effect magnitude and precision, as well as clarity about 
the definition of a “traditional Mediterranean diet.”  The traditional Mediterranean diet consists 
of high intake of olive oil, vegetables, fruit, nuts, and whole-grain cereals; moderate intake of 
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fish, poultry, and low-fat dairy; and low intake of red meat, processed meats, and sweets.  Wine 
is consumed in moderation with meals. 
 
Results 
The search strategy yielded 749 results using both “Mediterranean diet” and “cardiovascular 
diseases.”  The results were filtered for language, human subjects, full text availability, and 
clinical studies or trials yielding 198 articles.  Title review for relevance narrowed the search to 
24 articles and abstract review narrowed it further to 9 articles.  Only 5 of those were published 
after 2006 and therefore underwent full text review.  These five articles were deemed to have 
acceptable study design and unique data.  The process by which the literature search was 
performed is summarized in Figure 1. 
 
Of the five articles chosen for review, two were randomized controlled trials (RCT) that 
compared a Mediterranean diet to a low-fat diet.
13,14
  The PREDIMED trial was a very well-
designed large RCT.
13
  The other RCT also included a no dietary intervention control group 
however that comparison used an embedded case-control format.
14
  One other article was also a 
case-control study.
15
  The final two studies were retrospective analyses of large cohort studies: 
the Nurses’ Health Study16 and the Seguimiento Universidad de Navarra (SUN) project.17  
Overall quality of the studies was fair due to mostly retrospective study designs, measurement 
bias, and poor external validity.  Many of the studies did have large sample sizes.  There were 
well-defined outcomes and the direction of the findings was consistent across studies with 
similar magnitude though specific outcomes measures were different across studies.  Authorship, 
publication information, study design, population, methods, and results are outlined in Table 1. 
35 
 
 
Analysis 
The first article by Estruch et al.
13
 was a randomized controlled trial, PREDIMED, with over 
7,000 study participants that compared a Mediterranean diet supplemented with either 4 
tablespoons of extra virgin olive oil per day or 30 grams of nuts per day to a control lower-fat 
diet to see if the intervention diets improved cardiovascular outcomes compared to the control 
diet with a composite endpoint of MI, CVA, and cardiovascular mortality.  As a randomized 
controlled trial, it has a much stronger study design than any of the other articles and still has a 
large, respectable sample size. It is different from some of the other studies in that it does not 
have a “no intervention” or no recommendation dietary control group.  All study participants 
were recommended to adhere to some dietary pattern.  This study was also notable for the 
magnitude of the effect.  In fact, the study was stopped early because of the magnitude of the 
findings. 
 
PREDIMED enrolled participants who were deemed to be at high CVD risk by the presence of 
either diabetes or at least three other cardiovascular risk factors (including smoking, 
hypertension, elevated LDL levels, low HDL levels, overweight or obesity, and a family history 
of premature coronary heart disease).  Participants were older on average than the other studies 
with an age range of 55-70.  It was also a primary prevention study so participants did not have 
CVD at baseline (which differs from the other RCT). 
 
The study found that intervention arms had a 30% reduced risk of CVD compared to controls.  
These findings went against a lot of popular beliefs that a “healthy” diet should be low-fat.  In 
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fact, the Mediterranean dietary intervention used in this study was calorie unrestricted and 
actually encouraged the use of high-fat supplemental extra virgin olive oil (EVOO) and nuts in 
the two intervention arms, respectively.  Yet, even with these higher fat intervention diets, the 
magnitude of the findings was significant.  Other strengths are that the RCT study design 
suggests a causal role for a Mediterranean diet in cardiovascular disease prevention and 
eliminates confounding. 
 
A limitation of the study is that the findings may not be generalizable to individuals who do not 
have a high baseline cardiovascular risk profile, although the diet may reduce CVD risk across 
different baseline risks.  Also, the study demonstrated efficacy of both intervention arms with 
supplemental EVOO and nuts; however, it’s unclear how effective the diet is in a real-world 
situation where individuals are not given free EVOO and nuts to consume.  Observed rates of 
cardiovascular events were lower than expected so the study was not powered to assess the 
individual components of the primary composite outcome.  Finally, because the study was 
performed in Spain where many may eat a Mediterranean diet at baseline, the between-group 
differences were modest aside from the supplemental EVOO and nuts which suggests that those 
may be responsible for the observed benefits rather than providing evidence that the 
Mediterranean diet as a whole was responsible for the observed outcomes. 
 
The second article by Kastorini et al.
15
 was a multi-center case-control study that enrolled 250 
participants each with first acute coronary syndrome or ischemic stroke with 500 age- and sex-
matched controls.  Their study looked at the association between adherence to a Mediterranean 
diet and incidence of a first coronary event or ischemic stroke.  Although all of the studies 
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included in this review included strokes in their measured outcomes, this study was notable for 
focusing on the association between adherence to a Mediterranean diet and stroke specifically; 
therefore, odds ratios were calculated separately for stroke incidence. 
 
It was a multi-center study that enrolled consecutive individuals with first time MI or ischemic 
stroke without suspicion of previous CVD and 1:1 matched controls.  They had relatively few 
exclusion criteria which were comorbid chronic neoplasm, chronic inflammatory disease, and 
recent dietary changes.  ACS cases were younger and more likely to be male than CVA cases.  
Controls had higher baseline MedDietScores, were more physically active, and less likely to 
smoke.  They also had lower prevalence of diabetes, hypertension, and family history of CVD.  
After controlling for potential confounders, the study authors found a 0.91 and 0.88 odds of 
developing ACS and ischemic CVA, respectively, for each 1-unit increase in MedDietScore (out 
of 55) which assesses adherence to a Mediterranean diet. 
 
Limitations of this study include its retrospective design and inability to control for all potential 
confounders.  Dietary reporting is subject to recall bias.  Additionally, the diet log was recorded 
during the first 3 days of hospitalization which may not represent a typical diet for those 
participants.  Furthermore, people with disease will tend to over-report unhealthy dietary habits.  
The study is subject to survivor bias.  Finally, bias may have been introduced for stroke patients 
who could not communicate well and required a surrogate to answer study questions for them. 
 
The third article by Martinez-Gonzalez et al.
17
 was a cohort study that used data from the 
Seguimiento Universidad de Navarra (SUN) project with over 13,000 participants to evaluate the 
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association between Mediterranean diet adherence and incident cardiovascular disease (including 
cardiovascular death, acute coronary syndrome (ACS), revascularization procedures, and fatal or 
non-fatal CVA).  Notable considerations about this study were that the study population was 
much younger than other studies because it was drawn from a cohort of university graduates; 
therefore despite the large cohort size, there were relatively few incident cases. 
 
Mean age of study participants was 38.  Participants with baseline prevalent CVD were 
excluded.  Median follow-up was 4.9 years and there were 100 cases of incident CVD.  Higher 
adherence scores were associated with increased physical activity profiles but also with risk 
factors for CVD: being an ex-smoker or having diabetes, hypertension, dyslipidemia, or a family 
history of coronary disease at baseline.  Multiple multi-variable-adjusted models all showed an 
inverse association between Mediterranean diet adherence and incident CVD.  A 2-point 
increment in Mediterranean diet score (out of 9) was associated with a 20% reduction in risk of 
CVD and 26% reduction in incidence of coronary heart disease. 
 
Limitations include the small number of incident events.  It’s also unclear how participants all 
being university graduates would affect its generalizability.  This study was inconsistent with 
some of the other literature in several ways.  They found cereal associated with increased CVD 
risk however their diet score does not differentiate between whole grain and refined cereals.  
Additionally, their principal component analysis yielded two vectors, one of which they called 
the “post hoc Mediterranean pattern” as it correlated with the consumption of vegetables, fruits, 
fish, poultry, low-fat dairy, whole grains, nuts, olive oil, and legumes; interestingly, this dietary 
pattern has a non-significant positive association with CVD. 
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The fourth article by Fung et al.
16
 was also a cohort study.  This study used data from Nurses’ 
Health Study with almost 75,000 women that evaluated the association between a Mediterranean 
diet adherence score and incident coronary heart disease and stroke.  This study was notable for 
the fact that they were able to assess dietary adherence at multiple time points over a 6-year 
period which may make it more reliable.  They were also able to follow participants over a much 
longer period of time (up to 20 years) and they had high follow-up rates despite the long duration 
of the study. 
 
Participants in the Nurses’ Health Study were women age 30 to 55 years at the time of 
enrollment in the United States.  During up to 20 years of follow-up, they ascertained 2391 cases 
of coronary heart disease (CHD) and 1763 cases of stroke.  At baseline, women with higher 
Mediterranean diet adherence scores (aMed score) exercised more and were less likely to be 
smokers; they consumed more calories and fiber but less saturated fat.  After adjusting for 
potential confounders, they found that women in the top quintile of aMed score had a relative 
risk (RR) of 0.71 compared to those in the bottom quintile.  A similar inverse association was 
observed for strokes with RR 0.87 for top quintile compared to bottom quintile.  Associations 
were stronger for fatal events. 
 
Limitations include residual confounding as it is an observational study and lack of 
generalizability to men since the study only enrolled women.  High follow-up rates reduced the 
probability of selection bias; repeated dietary assessments over time reduce the risk of 
measurement bias. 
40 
 
 
The fifth article by Tuttle et al.
14
 was a combination randomized controlled trial and case-control 
study.  The RCT compared a Mediterranean diet to a low-fat diet in 101 participants and the 
controls in the case-control had no dietary intervention or recommendation.  This study assessed 
the efficacy of a Mediterranean diet versus a low-fat diet in secondary prevention of 
cardiovascular disease (including ACS, CVA, hospitalization for heart failure, cardiac death, and 
all-cause mortality).  This study is notable because it assessed secondary prevention of CVD 
whereas the other studies in this literature review looked at primary prevention.  It is also notable 
because it tests a clinically-relevant comparison of whether Mediterranean or low-fat diet leads 
to better cardiovascular outcomes after MI in a prospective, randomized trial.   
 
Participants in this study all had a first MI as part of the inclusion criteria and were mostly 
middle-aged white men.  The study found no significant difference between the Mediterranean 
diet and a low-fat diet in secondary prevention of CVD however it demonstrated that both a 
Mediterranean diet and low-fat diet had reduced incidence of CVD compared to “usual care” or 
no dietary intervention with an adjusted OR of 0.28.   
 
A major limitation is the broad and non-specific composite primary outcome including all-cause 
mortality and heart failure.  In fact, the only 2 outcomes that were statistically significant 
individually were unstable angina and all-cause mortality (which may not have been related to 
CVD at all).  Other limitations include the small sample sizes and small number of CVD events 
(only 8 events in each RCT group).  This study may not be generalizable to populations without 
pre-existing CVD; individuals with pre-existing CVD may be more motivated to follow a dietary 
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intervention and therefore the outcomes may be exaggerated.  There is significant selection bias 
as the true controls (that led to the only significant findings) were case-controls instead of a third 
arm in the RCT.  The study was designed that way because referring physicians had indicated 
that they would not refer their patients to the study if there was a risk of being assigned to a non-
intervention arm after an MI.  They felt it would be unethical as prior studies had shown benefit 
to dietary modification after MI. 
 
Discussion 
Overall strength of the evidence for a Mediterranean diet reducing the risk of cardiovascular 
disease is fairly good.  The studies included in this literature review each have limitations but the 
direction of the findings is consistent across all of the studies, suggesting that a Mediterranean 
diet does in fact reduce the risk of cardiovascular disease.  Study samples are heterogeneous 
(some younger; some older; some only have women; most with no prior CVD and a range of 
CVD risk factors; one where all participants had prior CVD) in addition to sampling from 
populations in different regions of the world.  Two of the five studies were very good quality 
studies.  Some had inherent problems with the study designs.  Only one study was a large, multi-
center randomized controlled trial with minimal selection and measurement bias however even 
that study (PREDIMED) was unable to confidently attribute the positive outcomes to the 
Mediterranean diet as a whole; rather they suggested the reduction in CVD may be attributable to 
the supplemental EVOO and nuts.
13
  That being said, the traditional Mediterranean diet has been 
consistently associated with reduced CVD and mortality, across studies, including those 
performed before 2006, not included in this literature review.  The findings in the included 
articles in this review are consistent with the literature prior to 2006.
18,19
  One inherent challenge 
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with any study or trial looking at a Mediterranean diet, or any diet for that matter, is 
measurement bias from either recall bias or social desirability reporting bias.  Dietary surveys 
and even food diaries have not been shown to be fully accurate or representative of an 
individual’s overall diet quality;20 however, valid, reliable, accurate, and affordable alternatives 
are lacking to provide a perfect representation of true diet.  There are some biomarkers that can 
give a more objective indication of dietary adherence and quality however levels can change 
over time and the tests can be expensive.   
 
Slight discrepancies in adherence measurement tools and study designs make it still unclear 
which aspects of the Mediterranean diet or which combinations of the many dietary components 
of the Mediterranean diet are most beneficial in reducing CVD.  The magnitude of the protective 
effect of a Mediterranean diet in the United States is still yet to be determined with a large, 
multi-center, randomized controlled trial. 
 
One interesting finding across several of the studies was that the inverse association between a 
Mediterranean diet and mortality (both disease-specific and overall) tended to be stronger than 
the inverse association between the Mediterranean diet and the disease itself.  This suggests that 
the diet may mediate cardiovascular disease through a mechanism that is common to other 
diseases as well that can also result in death.  For example, some studies have shown that a 
Mediterranean diet can reduce inflammatory markers that may play a role in multiple disease 
processes. 
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A causal protective relationship was suggested by the PREDIMED randomized controlled trial.
13
  
To determine the absolute effect a Mediterranean diet has on preventing CVD in the United 
States, future studies should have a randomized controlled trial study design.  Future studies 
could be modeled after PREDIMED but with a no intervention control arm and a more “pure” 
intervention arm with no supplemental oils or nuts, to make the study more externally valid.  
Basing the large RCT in the United States would show benefits relative to a standard U.S. diet 
(whereas the baseline diet for the intervention and control groups were too similar in 
PREDIMED which was based in a Mediterranean region). 
 
Conclusion 
When taken together, the data from these studies strongly suggest that a Mediterranean diet does 
reduce the risk of CVD. 
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Figure 1. Study selection flow diagram 
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- Only one aspect of a Mediterranean diet studied 
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Abstracts reviewed for relevance (n=24) 
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Excluded (n=4) 
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- Looked at intermediate outcomes 
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- Multiple articles from the same study/same data set 
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Table 1. Study profiles 
Study citation Design Population Methods Outcome measure Results Quality 
rating 
Estruch R, Ros 
E, Salas-
Salvado J, et al. 
NEJM 201313 
Multi-center 
randomized 
controlled 
trial 
7,447 participants 
in Spain ages 55-
70 with no CVD 
at enrollment but 
high-risk: either 
+DM or 3+ other 
CVD risk factors  
Randomly 
assigned to 1 of 
3 diets: Med diet 
+ EVOO, Med 
diet + mixed 
nuts, or low-fat 
control diet; also 
received dietary 
education 
Composite: MI, 
CVA, and death 
(from 
cardiovascular 
causes) 
HR 0.70 for 
Med diet + 
EVOO and HR 
0.72 for Med 
diet + mixed 
nuts (compared 
to controls) 
Excellent 
Kastorini C-M, 
Milionis HJ, 
Ioannidi A, et 
al. American 
Heart Journal 
201115 
Multi-center 
case-control 
study 
1,000 participants 
in Greece: 250 
with first ACS, 
250 with first 
ischemic CVA  
(without suspicion 
of previous CVD) 
and 500 age- and 
sex-matched 
controls 
Assessed 
adherence to a 
Med diet using 
validated 
MedDietScore 
from dietary 
recall and 3-day 
food record 
First ACS or first 
ischemic CVA 
OR 0.91 for 
ACS and OR 
0.88 for each 1-
unit increase in 
the 
MedDietScore 
(out of 55) 
Fair 
Martinez-
Gonzalez MA, 
Garcia-Lopez 
M, Bes-
Rastrollo M, et 
al. Nutrition, 
Metabolism, & 
Cardiovascular 
Diseases 201117 
Cohort study 13,609 university 
graduates in Spain 
(part of the SUN 
project) initially 
free of CVD 
(average age 38) 
Used a food-
frequency 
questionnaire to 
assess baseline 
diet then 
appraised 
adherence to 
Med diet using a 
9-point score 
Combined: 
incident 
cardiovascular 
death, ACS, 
revascularization 
procedures, fatal 
CVA, or non-fatal 
CVA 
HR 0.41 for 
Med Diet 
adherence score 
> 6 (compared to 
< 3); adjusted 
HR 0.80 for 
each 2-unit 
increase in 
adherence score 
(out of 9)  
Fair 
Fung TT, 
Rexrode KM, 
Mantzoros CS, 
et al. Circulation 
200916 
Cohort study 74,886 women 
age 38-63 in the 
Nurses’ Health 
Study with no 
history of CVD or 
DM 
Computed an 
Alternate 
Mediterranean 
Diet Score from 
self-reported 
dietary data 
through food 
frequency 
questionnaires 
administered 6 
times over 20 
years 
Incident cases of 
CHD (nonfatal 
MI or fatal CHD) 
and CVA 
2391 incident 
CHD, 1763 
incident CVA, 
1077 CVD 
deaths  RR 
0.71 for CHD, 
RR 0.87 for 
CVA, RR 0.61 
for CVD 
mortality 
(comparing top 
Med Diet score 
quintile to 
bottom quintile) 
Very 
good 
Tuttle KR, 
Shuler LA, 
Packard DP, et 
al. American 
Journal of 
Cardiology 
200814 
Randomized 
controlled 
trial 
comparing 
Med diet to 
low-fat diet + 
case-control 
analysis to 
compare to 
no dietary 
intervention 
(usual care) 
101 first MI 
survivors 
participated in 
RCT; controls in 
case-control 
analysis were 
matched for age, 
gender, MI 
type/treatment, 
diabetes status, 
and hypertension 
status 
Randomized to 
low-fat or 
Mediterranean-
style diet; also 
received 
individual 
dietary 
counseling 
Composite: all-
cause deaths, 
cardiac deaths, 
MI, hospital 
admission for 
heart failure, 
unstable angina, 
or CVA 
No difference 
between Med 
diet and low-fat 
diet but both 
were better than 
usual care 
(adjusted OR 
0.28) 
Fair 
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